Ingredient supplier Sabinsa Corp. is relocating the corporate office for Sabinsa Nanjing Biotechnology Company, Ltd., to a new site in Nanjing, China.
Ingredient supplier Sabinsa Corp. is relocating the corporate office for Sabinsa Nanjing Biotechnology Company, Ltd., to a new site in Nanjing, China. This new site will feature office space as well as warehousing, repacking, and quality-control areas. Sabinsa Nanjing Biotechnology is led by President Julia Wei.
The company says that the new, expanded site will enable it to better serve customers. In a press release, Sabinsa’s founder and group chairman of the Sami-Sabinsa Group, Muhammed Majeed, PhD, said, “The workspace is officially open, and the team is happy to host its customers and partners to continue the successful journey together.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.